Navigation Links
NovoCure Ltd. announces closing of financing round
Date:9/28/2009

ntly completed enrollment of a 236-patient, multi-center, randomized Pivotal clinical trial studying the safety and efficacy of the Novo-TTF device treating patients with recurrent GBM compared to standard-of-care chemotherapy. The results of this trial will be presented to the Food and Drug Administration (FDA) as part of a PMA application planned for early next year.

A new, multi-center, Pivotal clinical trial to study the efficacy of the novel Novo-TTF device in combination with standard-of-care chemotherapy (temozolomide) compared to standard-of-care chemotherapy alone in patients with newly-diagnosed GBM is now open in the United States, Europe and Israel. Data from a Pilot study of Novo-TTF in combination with chemotherapy in patients with newly diagnosed GBM suggest that the device may significantly improve upon the standard-of-care when used in combination with chemotherapy. As published in BMC Medical Physics in January of this year, patients treated with TTFields in a Pilot clinical trial for newly diagnosed GBM showed a median time to disease progression of 155 weeks compared to approximately 31weeks for concurrent control patients receiving standard-of-care chemotherapy alone. With 80% still living at the time of publication, the TTF treated patients had not yet reached the median overall survival at 39 months, compared to historical published median overall survival of 14.6 months for newly diagnosed GBM patients receiving standard-of-care chemotherapy alone. The ability to add the Novo-TTF to standard-of-care chemotherapy with minimal additional toxicity makes the treatment particularly attractive. Details about the newly diagnosed GBM trial including trial locations can be found on the NovoCure website (www.novocuretrial.com).


'/>"/>

Contact: Jennifer Paganelli Schwartz
jennifer.schwartz@edelman.com
212-642-7774
Edelman Public Relations
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. NovoCure presents results from breast cancer pilot study
2. RCRC Independent Review Board Announces DHHS Research Oversight
3. change:healthcare Announces Twitter Application that brings Healthcare Information and Costs to Consumers' Fingertips
4. QRxPharma Announces Strategic Alliance with Liaoning Nuokang Medicines Co Ltd for the Development of Venomics Assets
5. I-Therapeutix, Inc. Announces Company Name Change
6. President Clinton Hosts Special Session on Northern Ireland; Announces New Commitments Focused on Harnessing Innovation for Development
7. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of Directors
8. US Farms, Inc. Announces Broker Network Agreement With Sunshine Specialties for Aloe365 Products
9. ReBuilder Medical Technologies, Inc. Announces Medicare Billing Ability for its ReBuilder Product
10. Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics (TCT) Meeting
11. Strategic Information Group Announces QAD Enterprise Validation Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... CoCENTRIX, a leading provider of coordinated ... Services and community providers, announced today that the ... CoCENTRIX Coordinated Care Platform (CoCENTRIXccp) as ... and coordinate care within and amongst its four ... transitioning the hospitals' official records from paper-based to ...
(Date:5/22/2013)... Denver, CO (PRWEB) May 22, 2013 ... of legal discovery management services for law firms, corporations ... Cumulus Data, Inc., a cloud-based e-discovery software company, to ... of this newly formed partnership, Cumulus Data and LDM ... Standard, downtown LA on Tuesday, May 21st. This ...
(Date:5/22/2013)... 2013 BroadConnect Telecom, the leading ... security solutions in North America announced plans to ... newest BroadConnect hosted security solutions. Available on premise, ... BroadConnect’s new Security as a Service (SaaS) enables ... connection of their choice, while optimizing internal network ...
(Date:5/22/2013)... Poor adherence to appropriate medication therapy has ... and death (some 125,000 deaths in the U.S. every ... costs. It’s been estimated that between 33% and 69% ... medication adherence — a reality that costs the American ... dire is the degree of medication non-adherence — and ...
(Date:5/22/2013)... Dallas, TX (PRWEB) May 22, 2013 Mari’s ... in Dallas, has become the first in the state of ... is called Meta Therapy- Medical and Esthetic Tissue Activation, also ... used for over four years in Europe, but has just ... Meta Therapy improves the skin from inside out by building ...
Breaking Medicine News(10 mins):Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 2Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 3Health News:LDM Global Enhances Forensic Data Collection Services with eCloudCollect 2Health News:LDM Global Enhances Forensic Data Collection Services with eCloudCollect 3Health News:BroadConnect Telecom to Launch Enterprise-Grade Hosted Security Solutions Engineered to Meet the Demands of Real World Business 2Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2Health News:Mari's to Offer New Treatment from Europe 2
... Government medical services in Andhra Pradesh came to ... indefinite// strike enters the second day. ,Patients ... emergency services. Patients seeking immediate medical assistance had ... prevailed at the Osmania General Hospital and the ...
... about the hearing loss caused by the MP3 players, ... paying// any heed to those warnings. But sensing the ... limiting the volume on the devices. ,The American ... to the ears associated with MP3 players. The ASHA ...
... A relatively new kind of antibiotic has been found to ... is necessary// before the drug can be prescribed, says a ... around the world, causes inflammation of the airways, or bronchi, ... thereby disrupting breathing. ,During an asthmatic attack, the ...
... Special K Snack Bites are Kellogg’s latest additions to ... on-the-go consumer//. ,The Granola Munch'ems snack bites ... and minerals such as Vitamin A, Vitamin B6, Thiamin, ... available as bite-sized-morsels in individual pouches which are available ...
... new research, men who have elevated levels of testosterone ... but may lead shorter lives// when compared with men ... ,According to foodconsumer.org, comparative studies have studied testosterone levels ... very few studies have attempted to relate testosterone to ...
... of Prestbury Avenue, Newcastle-under-Lyme, Staffs, was found not guilty of ... the manslaughter of a baby who died of head injuries ... Crown Court took five hours to reach their verdict. Passing ... the family. ,Dr El-Khadem an Egyptian by birth ...
Cached Medicine News:Health News:Doctors Strike In Andhra Enters The Second Day 2Health News:Sensing The Health Hazard MP3 Makers Tone Down The Volume 2
(Date:5/22/2013)... , May 22, 2013  Grifols, a global ... , presented results from a study demonstrating that a ... Inhibitor [Human]) increased levels of the alpha 1 ... to levels that are considered within the normal range ... condition in which low levels of the alpha 1 ...
(Date:5/22/2013)... , May 22, 2013  BD (Becton, Dickinson ... global medical technology company, announced today the publication of ... fifth Sustainability Report and it continues to focus on ... "We believe the principles of shared value — ... healthcare challenges of societies — are fundamental to our ...
(Date:5/22/2013)... , May 22, 2013 Rigel Pharmaceuticals, Inc. ... advancement of three programs in development. The first program ... inhibitor, R348, being developed by Rigel as a treatment ... aimed at oncology targets and are being conducted by ... by BerGenBio AS (BerGenBio) and a ligase inhibitor under ...
Breaking Medicine Technology:Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4BD Issues 2012 Sustainability Report 2BD Issues 2012 Sustainability Report 3Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4
... YORK, Jan. 11, 2011 Reportlinker.com announces that ... its catalogue: Advanced Drug Delivery ... http://www.reportlinker.com/p0358466/Advanced-Drug-Delivery-Markets-Liposomes-Polymers-and-Monoclonal-Antibodies.html Drug delivery ... drug product formulations being discovered frequently. Advanced drug ...
... NEW YORK, Jan. 11, 2011 Reportlinker.com announces ... in its catalogue: Innovative Drug ... http://www.reportlinker.com/p0359990/Innovative-Drug-Discovery-in-Emerging-Markets.html Introduction Emerging markets ... pharmaceutical industry, but it has been unclear the ...
Cached Medicine Technology:Reportlinker Adds Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies) 2Reportlinker Adds Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies) 3Reportlinker Adds Innovative Drug Discovery in Emerging Markets 2Reportlinker Adds Innovative Drug Discovery in Emerging Markets 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: